Drug industry

Drug industry

Gender and the gene giants: research and action on women and the new genetics

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Centres of Excellence for Womens Health (CEWH)
National Network on Environment and Women's Health (NNEWH)
Women's Health New Genetics (WHNG)
Media Type: 
Paper
Online
Author: 
Julie Delahanty
Publisher: 
National Network on Environments and Women's Health
Publication Date: 
2000
Publication Place: 
Toronto, ON

Provides discussion on four issues, including: the use of genetic research in the pharmaceutical industry; the corporate concentration in the life industries; the terminator and traitor technologies; and, the threat of genetic biowarfare. Outlines gender-equality concerns and issues for further research and action.

ISBN/ISSN: 
NNEWH NRGT.G46 2000
Notes: 
Chapter in "The Gender of Genetic Futures: The Canadian Biotechnology Strategy, Women and Health." Includes bibliographical references.

Women's cycles up for sale: neo-medicalization and women's reproductive health

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Women and Health Protection (WHP)
Media Type: 
Paper
Online
Author: 
Abby Lippman
Women and Health Protection
Publisher: 
Network/Le Réseau
Publication Date: 
2004
Publication Place: 
Winnipeg, MB

Examines the medicalization of women's reproductive functions, including treating normal health cycles as problems or illnesses.

ISBN/ISSN: 
ISSN 14800039

Synthesising licensing data to assess drug safety

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Klim McPhersron
Elina Hemminki
Publisher: 
British Medical Journal
Publication Date: 
2004
Publication Place: 
London, UK

Argues that if trials done by pharmaceutical companies for licensing purposes had to include adequate data on harms and ineffectiveness the medical community could learn much more quickly what they need to know about new drugs. Contends that the risks of hormone replacement therapy would have been revealed much earlier if better use had been made of existing evidence, and as such, women have been needlessly exposed to an increased risk of heart disease.

Available From: 
ISBN/ISSN: 
ISSN 14685833

Patents, pills and public health: can TRIPS deliver?

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Publisher: 
Panos Institute
Publication Date: 
2002
Publication Place: 
London, UK

Aims to provide the media, policy-makers, non-governmental organizations and other concerned groups with an introduction to the issues surrounding the international agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and public health.

Available From: 
ISBN/ISSN: 
PHAR.P36 2002

German Federal Congress of Development Action Groups

Text Size: Normal / Medium / Large
Organization Type: 
NGO - Non Government Organization
Service Language: 
English
German
Services Provided: 
Health promotion
Community education/development
Advocacy

Encourages rational use of drugs. Advocates against irresponsible business practices of multinational pharamaceutical companies, focussing on Germany and various Third World countries. Cooperates with doctors and pharmacists, consumer organisations, students and a network of 200 Third World groups in Germany. Collaborates with groups in more than 70 countries through participation in network of Health Action International (HAI).

Contact Info
Primary Telephone: 
01 (49) 0521 6 05 50
Email Address: 
info@bukopharma.de
Website/URL: 
Fax Number: 
01 (49) 0521 6 37 89
Street Address: 
August-Bebel-Straße 62
City: 
Bielefeld
Postal/ZIP Code: 
D-33602
Internal Notes : 
Multiple URL found: "http://www.bukopharma.de and http://www.bukopharma.de/English/english.htm"

No life without pills?: the medicalisation of daily life

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Author: 
Hedwig Diekwisch
Christiane Fischer
Jörg Schaaber
BUKO Pharma-Kampagne
German Federal Congress of Development Action Groups (BUKO)
Irene Grevelding
Publisher: 
BUKO Pharma-Kampagne = BUKO Pharma Campaign
Publication Date: 
2002
Publication Place: 
Bielefeld, DE

Examines problems of pharmaceuticals and their overuse in Germany, defined as the problem of medicalisation. Compares and contrasts effects in some Third World southern countries. Encourages consumer awareness and skepticism.

ISBN/ISSN: 
PHAR.N65 2002

Public funding of pharmaceutical company R&D: where does the public interest lie?

Tagged :
Print
Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Online
Author: 
Martin Petit
Publisher: 
DES Action Canada
Publication Date: 
2000
Publication Place: 
Montreal, QC

Examines how pharmaceutical companies receive public funding for research and development (R&D) by way of tax benefits and federal public investment programs.

Available From: 

Drug company money: to accept or not to accept? Is that the question?

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Online
Author: 
Rosanna Baraldi
Publisher: 
DES Action Canada
Publication Date: 
1997
Publication Place: 
Montreal, QC

Discusses and debates the funding of women's health groups by drug companies. Presents arguemtns for both sides.

Available From: 

Newspapers highlight benefits of new drugs, ignore risks: consumers aren't getting balanced information about new prescription

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Media Type: 
Paper
Online
Author: 
Canadian Centre for Policy Alternatives
Publisher: 
Le Réseau/Network
Publication Date: 
2003
Publication Place: 
Winnipeg, MB

Summarizes findings of a report, "Drugs in the News," that found that newspaper articles more often emphasize the benefits of new drugs, while little attention is paid to possible harms. Includes a listing of known risks of new prescription drugs that are not listed in media reports, such as drug indications and contraindications, clinical benefits and harms, costs, etc.

ISBN/ISSN: 
ISSN 14800039

Direct-to-consumer prescription drug advertising: the European Commission's proposals for legislative change

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Barbara Mintzes
Publisher: 
Health Action International
Publication Date: 
2001
Publication Place: 
Amsterdam, The Netherlands

Discusses proposed changes to European law to allow advertising of prescription drugs to treat AIDS, diabetes and asthma. Reviews evidence on effects of direct-to-consumer advertising.

ISBN/ISSN: 
PHAR.M56 2001
Notes: 
Includes bibliographical references.
Syndicate content